Shengye Liu
发表
Q. Fu,
Liyu Yang,
Shuai Mu,
2018,
Front. Pharmacol..
Yuhong Zhao,
Qijun Wu,
Guang-bin Wang,
2021,
Frontiers in Physiology.
Ran Guo,
Q. Fu,
Yan Li,
2018,
Biochemical and biophysical research communications.
Q. Fu,
Liyu Yang,
Lei Yang,
2019,
Molecular medicine reports.
Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma
Q. Fu,
Xuechen B Yu,
Jiamei Liu,
2020,
Frontiers in Oncology.
Ran Guo,
Q. Fu,
Long Zhou,
2021,
Evidence-based complementary and alternative medicine : eCAM.
Q. Fu,
Qianqian Wu,
Liyu Yang,
2016,
Molecular medicine reports.
Liyu Yang,
Shengye Liu,
F. Qin,
2022
.
Q. Fu,
Jiamei Liu,
Shengye Liu,
2020,
Cartilage.
Yu Deng,
D. Liao,
Xi-ping Cheng,
2022,
Archives of rheumatology.
Q. Fu,
Jiamei Liu,
Liyu Yang,
2020,
Frontiers in Oncology.
Jiamei Liu,
Xianghong Yang,
Shengye Liu,
2021,
Frontiers in Oncology.
Jiamei Liu,
Liyu Yang,
Shengye Liu,
2023,
BMC Cancer.
Q. Fu,
Zhiguang Chen,
Liyu Yang,
2018,
International journal of molecular medicine.
Q. Fu,
Long Zhou,
Liyu Yang,
2018,
Oncotarget.
Shengye Liu,
2017
.
Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma
Q. Fu,
Jiamei Liu,
T. Shen,
2020,
Frontiers in Oncology.
Jiamei Liu,
Liyu Yang,
Shengye Liu,
2023,
Life sciences.